A detailed history of Vista Capital Partners, Inc. transactions in Absci Corp stock. As of the latest transaction made, Vista Capital Partners, Inc. holds 58,317 shares of ABSI stock, worth $148,708. This represents 0.0% of its overall portfolio holdings.

Number of Shares
58,317
Previous 58,317 -0.0%
Holding current value
$148,708
Previous $179,000 24.02%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$2.92 - $6.58 $18,980 - $42,770
-6,500 Reduced 10.03%
58,317 $179,000
Q1 2024

May 03, 2024

SELL
$3.41 - $5.74 $71,610 - $120,540
-21,000 Reduced 24.47%
64,817 $368,000
Q4 2023

Feb 08, 2024

SELL
$1.15 - $4.79 $2,300 - $9,580
-2,000 Reduced 2.28%
85,817 $360,000
Q3 2022

Nov 07, 2022

SELL
$2.95 - $4.83 $17,700 - $28,980
-6,000 Reduced 6.4%
87,817 $275,000
Q2 2022

Aug 08, 2022

BUY
$3.13 - $8.83 $293,647 - $828,404
93,817 New
93,817 $311,000

Others Institutions Holding ABSI

About Absci Corp


  • Ticker ABSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 92,843,504
  • Market Cap $237M
  • Description
  • Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....
More about ABSI
Track This Portfolio

Track Vista Capital Partners, Inc. Portfolio

Follow Vista Capital Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vista Capital Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Vista Capital Partners, Inc. with notifications on news.